When EU legislation on pharmacovigilance came into force in July 2012, it established the clear legal requirement that marketing authorisation holders must perform a...

Automating regulatory processes delivers undeniable benefits, ranging from accelerating time to market to reducing error. But life sciences companies are widely grap...

The COVID-19 pandemic has stretched healthcare suppliers, organisations, governments, and healthcare professionals to their very limits, locking down the world like ...

The development of vaccines to prevent COVID-19 has become a fascinating story, especially for those with an interest in life sciences. In the development of COVID-1...

The COVID-19 pandemic era is shaking up the pharma supply chain. Heavily regulated processes that used to take years are speeding up as existing drugs are repurposed...

In June, the first part of this article was published, describing differences in the legal background of some of the European Union countries, which need to be known...

Under growing pressure resulting from staff shortages, overburdened funding, an ageing population and most recently a global pandemic, healthcare systems across the ...

In the quest to find new and more effective treatments against severe diseases, researchers are increasingly moving towards active pharmaceutical ingredients (APIs) ...

Recent data suggest that 339M people globally have asthma, resulting in 425,000 deaths annually, many of which would be preventable with access to medication and app...

Recent decades have seen vast technological developments all over the world, particularly in respiratory drug development. Respiratory drug delivery has equally been...